Vedolizumab treatment in patient with XLA, is it safe and efficient?

Copy For Citation

ÇEKİÇ Ş., Ozgur T., Karali Y., Ozkan T., Kilic S. Ş.

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Munich, Germany, 26 - 30 May 2018, pp.768-769, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• City: Munich
• Country: Germany
• Page Numbers: pp.768-769
• Bursa Uludag University Affiliated: Yes